Poultry

Case study · · 5 min read

Funding the evidence: IFT's support for avian influenza research in Egypt

Since 2012, peer-reviewed papers have recorded IFT as a full or part funder of avian influenza research in Egyptian poultry. What they found.

Speaker at the Damanhour University lectern, the Egyptian and university flags beside him. Company photograph.
Speaker at the Damanhour University lectern, the Egyptian and university flags beside him. Company photograph.

Avian influenza viruses in Egyptian poultry keep changing, and a vaccination programme is only as current as the field data behind it. Peer-reviewed papers published since 2012 record IFT helping to pay for the field research, led by universities and research institutes, that produces that data, and, for some studies, helping to ship the samples. This is what those papers report, and what IFT did.

The challenge: a virus that keeps moving

In 2018, researchers at Germany’s Friedrich-Loeffler-Institut and at Egyptian universities and institutes described highly pathogenic H5N1 avian influenza of clade 2.2.1 as endemic in poultry in Egypt. They recorded that the Egyptian virus had evolved into several genotypes over the previous 12 years, and that between 2007 and 2014 vaccinated poultry suffered from antigenic drift variants of clade 2.2.1.1 (Salaheldin et al., 2018). H9N2 and, later, H5N8 have circulated alongside it.

A programme built around last decade’s virus may not match this year’s. Finding out what is circulating means sampling sick flocks on working farms, isolating and sequencing the virus, and sometimes shipping samples to partner laboratories in Europe. That work belongs to independent laboratories, and it costs money.

What IFT did

The papers record IFT’s role as funding, in full or in part, and help with shipping field samples. The universities and institutes named on each paper carried out the studies and wrote the conclusions. The 2017 and 2018 papers both state that the funders had no role in study design, data collection and analysis, the decision to publish or preparation of the manuscript (2017, 2018).

Published Paper Research partners named on the paper IFT’s role as the paper records it
2012 Monne et al., Influenza and Other Respiratory Viruses 7(3):240-243 (DOI) Istituto Zooprofilattico Sperimentale delle Venezie (IZSVe, Padova), Cairo University, Animal Health Research Institute Sample shipment and partial financing
2017 Salaheldin et al., Virology Journal 14:48 (DOI) Friedrich-Loeffler-Institut, Free University of Berlin, Alexandria and Damanhour universities, a Moscow veterinary academy Sample shipment and partial financing
2018 Salaheldin et al., Frontiers in Microbiology 9:528 (DOI) Friedrich-Loeffler-Institut, Free University of Berlin, University of Greifswald, Alexandria and Damanhour universities, two Egyptian research institutes Partial financing
2022 Salaheldin et al., Viruses 14(7):1431 (DOI) Alexandria, Damanhour, Sadat City and Assiut universities, Friedrich-Loeffler-Institut Funded by IFT
2023 Ghanem, Abdullatif and Hassanin, Avian Pathology 52(4):251-263 (DOI) Zagazig University Funder recorded as IFT in PubMed, Europe PMC and Crossref

The 2023 paper is on Newcastle disease vaccination in broilers, not avian influenza; it is listed because it continues the funding record.

What the papers found

2012: H9N2 on commercial farms

Monne and colleagues described H9N2 in Egyptian commercial broiler and broiler-breeder farms for the first time. The samples came from seven flocks (six broiler, one broiler-breeder) in Giza, Beheira, Dakahlia and Sharkia, between February 2010 and August 2011. They warned that H9N2 circulating in a population where H5N1 is endemic gives the viruses a chance to reassort and produce new ones (Monne et al., 2012).

2017: a new H5N1 subclade in vaccinated turkeys

A meat-turkey flock vaccinated twice with inactivated H5 vaccines lost about 29% of its birds within 10 days of the first clinical signs. The virus showed antigenic drift and grouped in a new subclade, which the authors named 2.2.1.2a. They suggest that enforcing biosecurity and constantly updating vaccine virus strains may help protect vaccinated birds (Salaheldin et al., 2017).

2018: why H5N1 persists

Winter temperatures influenced the spread of H5N1 in the areas studied and may contribute to more outbreaks in some regions. Viruses of clade 2.2.1.1 and recent clade 2.2.1.2 were more stable at 4°C and 56°C than the other viruses tested, and Pekin ducks shed virus for up to two weeks after infection. The authors suggest targeted surveillance and culling of silently infected Pekin ducks (Salaheldin et al., 2018).

2022: H5N8 in vaccinated and unvaccinated flocks

Between November 2019 and March 2021, vets and farmers submitted swabs from commercial chicken, duck and turkey flocks with respiratory signs and high morbidity and mortality. H5N8 was found in 88 of 211 flocks (41.7%): 65 of 144 vaccinated flocks (45.1%) and 23 of 67 non-vaccinated flocks (34.3%). The authors report that recent H5N8 viruses in Egypt, of clade 2.3.4.4b, are genetically distinct from the majority of licensed vaccines used in the field. Their abstract closes by recommending that current vaccines be evaluated regularly and updated, so that poultry flocks in Egypt are fully protected against H5N8 (Salaheldin et al., 2022).

The authors are writing about the vaccines in field use at the time, and IFT does not read the finding as a statement about any single product.

Using these papers in a programme review

  • Compare the sampling period and governorates with your own farms before drawing conclusions.
  • Note the subtype and clade each paper reports (H9N2; H5N1 2.2.1.1, 2.2.1.2 and 2.2.1.2a; H5N8 2.3.4.4b) and check which virus strains the vaccines in your programme are based on.
  • Read the results for vaccinated and non-vaccinated flocks separately.
  • Read the funding and acknowledgements sections to see who paid.

What we learned

Vets and integrators choose vaccination programmes on field evidence, and that evidence has to come from laboratories that publish under peer review. A distributor cannot produce it and should not try to shape it. It can help pay for the sampling and get samples to the laboratory, and we count that as part of the job.

IFT has contributed as an author too: a 2017 paper on vaccine immune pressure and avian influenza (Milani et al., Veterinary Microbiology) includes a co-author from IFT Corporation, Cairo.

For separate IFT field work on broiler respiratory disease, see the respiratory mortality case study. For vaccination practice, read Planning a Newcastle and avian influenza vaccination programme for broilers in Egypt.

Talk to IFT about your flock’s vaccination programme or about avian influenza research in Egypt: Contact Us.

By IFT Poultry Technical TeamPoultry

Work with IFT's poultry team.

Tell us about your operation and country. A vet from the right affiliate will reply.